COPD Exacerbation Follow Up
NCT07118306
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- COPD (Chronic Obstructive Pulmonary Disease)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Viz.ai, Inc.
- Last updated on ClinicalTrials.gov
- September 2, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Advocate Lutheran General Hospital · Park Ridge, IL
New Jersey · 1
- Cooper University Health Care · Cherry Hill, NJ
Pennsylvania · 1
- Thomas Jefferson University · Philadelphia, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.